{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:51:23Z","timestamp":1785898283051,"version":"3.56.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20441"],"award-info":[{"award-number":["20441"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["9965"],"award-info":[{"award-number":["9965"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10238-018-0536-z","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T11:11:26Z","timestamp":1542193886000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-5471","authenticated-orcid":false,"given":"Franco","family":"Dammacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Lauletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Manno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"536_CR1","first-page":"156","volume":"52","author":"MM Wintrobe","year":"1933","unstructured":"Wintrobe MM, Buell MV. Hyperproteinemia associated with multiple myeloma. Bull Johns Hopkins Hosp. 1933;52:156\u201365.","journal-title":"Bull Johns Hopkins Hosp"},{"key":"536_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00000441-194710000-00009","volume":"214","author":"AB Lerner","year":"1947","unstructured":"Lerner AB, Watson CJ. Studies of cryoglobulins. I. Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci. 1947;214:410\u20135.","journal-title":"Am J Med Sci"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0002-9343(62)90191-2","volume":"32","author":"J LoSpalluto","year":"1962","unstructured":"LoSpalluto J, Dorward B, Miller W, Ziff M. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. Am J Med. 1962;32:142\u20137.","journal-title":"Am J Med"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/0002-9343(66)90199-9","volume":"40","author":"M Meltzer","year":"1966","unstructured":"Meltzer M, Franklin EC. Cryoglobulinemia\u2014a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med. 1966;40:828\u201336.","journal-title":"Am J Med"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57:775\u201388.","journal-title":"Am J Med"},{"issue":"4","key":"536_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/0002-9343(87)90904-1","volume":"83","author":"L Bonomo","year":"1987","unstructured":"Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med. 1987;83(4):726\u201330.","journal-title":"Am J Med"},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/infdis\/162.2.569","volume":"162","author":"M Pascual","year":"1990","unstructured":"Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 1990;162:569\u201370.","journal-title":"J Infect Dis"},{"key":"536_CR8","first-page":"79","volume":"28","author":"PD Gorevic","year":"1991","unstructured":"Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes (CRI): implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol. 1991;28:79\u201394.","journal-title":"Semin Hematol"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1365-2362.1994.tb01077.x","volume":"24","author":"C Ferri","year":"1994","unstructured":"Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, et al. Hepatitis C virus infection in non-Hodgkin\u2019s B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest. 1994;24:781\u20134.","journal-title":"Eur J Clin Invest"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefr\u00e8re F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89\u201394.","journal-title":"N Engl J Med"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","volume":"101","author":"D Sansonno","year":"2003","unstructured":"Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood. 2003;101:3818\u201326.","journal-title":"Blood"},{"key":"536_CR12","first-page":"1164","volume":"32","author":"JW Levine","year":"2005","unstructured":"Levine JW, Gota C, Fessler BJ, Calabrese LH, Cooper SM. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol. 2005;32:1164\u20137.","journal-title":"J Rheumatol"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016;63:408\u201317.","journal-title":"Hepatology"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/art.1780361003","volume":"36","author":"G Abel","year":"1993","unstructured":"Abel G, Zhang QX, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum. 1993;36:1341\u20139.","journal-title":"Arthritis Rheum"},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10238-016-0410-9","volume":"16","author":"F Dammacco","year":"2016","unstructured":"Dammacco F, Racanelli V, Russi S, Sansonno D. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clin Exp Med. 2016;16:233\u201342.","journal-title":"Clin Exp Med"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MD.0b013e31829d2abc","volume":"92","author":"G Lauletta","year":"2013","unstructured":"Lauletta G, Russi S, Conteduca V, Sansonno L, Dammacco F, Sansonno D. Impact of cryoglobulinemic syndrome on the outcome of chronic hepatitis C virus infection: a 15-year prospective study. Medicine (Baltimore). 2013;92:245\u201356.","journal-title":"Medicine (Baltimore)"},{"key":"536_CR17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/art.1780341221","volume":"34","author":"C Ferri","year":"1991","unstructured":"Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991;34:1606\u201310.","journal-title":"Arthritis Rheum"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","volume":"327","author":"V Agnello","year":"1992","unstructured":"Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490\u20135.","journal-title":"N Engl J Med"},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2249.1992.tb03001.x","volume":"87","author":"F Dammacco","year":"1992","unstructured":"Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol. 1992;87:352\u20136.","journal-title":"Clin Exp Immunol"},{"key":"536_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-117-7-573","volume":"117","author":"R Misiani","year":"1992","unstructured":"Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992;117:573\u20137.","journal-title":"Ann Intern Med"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02592281","volume":"23","author":"F Dammacco","year":"1993","unstructured":"Dammacco F, Sansonno D, Cornacchiulo V, Mennuni C, Carbone R, Lauletta G, et al. Hepatitis C virus infection and mixed cryoglobulinemia: a striking association. Int J Clin Lab Res. 1993;23:45\u20139.","journal-title":"Int J Clin Lab Res"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0002-9343(94)90132-5","volume":"96","author":"P Cacoub","year":"1994","unstructured":"Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994;96:124\u201332.","journal-title":"Am J Med"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJMra1208642","volume":"369","author":"F Dammacco","year":"2013","unstructured":"Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med. 2013;369:1035\u201345.","journal-title":"N Engl J Med"},{"key":"536_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","volume":"106","author":"F Lunel","year":"1994","unstructured":"Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994;106:1291\u2013300.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"536_CR26","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/S1590-8658(07)80013-2","volume":"39","author":"MT Mascia","year":"2007","unstructured":"Mascia MT, Ferrari D, Campioli D, Sandri G, Mussini C, Ferri C. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis. 2007;39(Suppl 1):S61\u20134.","journal-title":"Dig Liver Dis"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","volume":"65","author":"B Terrier","year":"2015","unstructured":"Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, et al. Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015;65:74\u201381.","journal-title":"J Autoimmun"},{"issue":"Suppl 103","key":"536_CR28","first-page":"67","volume":"35","author":"M Galli","year":"2017","unstructured":"Galli M, Oreni L, Saccardo F, et al. HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). Clin Exp Rheumatol. 2017;35(Suppl 103):67\u201376.","journal-title":"Clin Exp Rheumatol"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/jmv.20695","volume":"78","author":"N Kosmas","year":"2006","unstructured":"Kosmas N, Kontos A, Panayiotakopoulos G, Dimitrakopoulos A, Kordossis T. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients. J Med Virol. 2006;78:1257\u201361.","journal-title":"J Med Virol"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.dld.2016.03.018","volume":"48","author":"C Mazzaro","year":"2016","unstructured":"Mazzaro C, Dal Maso L, Urraro T, Mauro E, Castelnovo L, Casarin P, et al. Hepatitis B virus related cryoglobulinemic vasculitis: a multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie\u2014GISC. Dig Liver Dis. 2016;48:780\u20134.","journal-title":"Dig Liver Dis"},{"key":"536_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/gastro\/gox021","volume":"5","author":"F Bazerbachi","year":"2017","unstructured":"Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S. Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation? Gastroenterol Rep (Oxf). 2017;5:178\u201384.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"536_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.autrev.2013.11.005","volume":"13","author":"G Monti","year":"2014","unstructured":"Monti G, Saccardo F, Castelnovo L, Novati P, Sollima S, Riva A, et al. Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. Autoimmun Rev. 2014;13:609\u201314.","journal-title":"Autoimmun Rev"},{"key":"536_CR33","unstructured":"Meeting of the International Task Force for Disease Eradication, June 2017. Wkly Epidemiol Rec. 2017;92:537\u201356."},{"key":"536_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00945029","volume":"19","author":"V Agnello","year":"1997","unstructured":"Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol. 1997;19:111\u201329.","journal-title":"Springer Semin Immunopathol"},{"key":"536_CR35","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","volume":"42","author":"P Lamprecht","year":"1999","unstructured":"Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum. 1999;42:2507\u201316.","journal-title":"Arthritis Rheum"},{"key":"536_CR36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","volume":"18","author":"C Ferri","year":"2006","unstructured":"Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol. 2006;18:54\u201363.","journal-title":"Curr Opin Rheumatol"},{"key":"536_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/rheumatology\/kel425","volume":"46","author":"D Sansonno","year":"2007","unstructured":"Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford). 2007;46:572\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"536_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12016-007-8070-x","volume":"35","author":"P Cacoub","year":"2008","unstructured":"Cacoub P, Saadoun D. Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol. 2008;35:30\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"536_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379:348\u201360.","journal-title":"Lancet"},{"key":"536_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","volume":"46","author":"M Fabris","year":"2007","unstructured":"Fabris M, Quartuccio L, Sacco S, De Marchi G, Pozzato G, Mazzaro C, Ferraccioli G, Migone TS, De Vita S. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford). 2007;46:37\u201343.","journal-title":"Rheumatology (Oxford)"},{"key":"536_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2249.2012.04653.x","volume":"170","author":"G Lake-Bakaar","year":"2012","unstructured":"Lake-Bakaar G, Jacobson I, Talal A. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia. Clin Exp Immunol. 2012;170:231\u20137.","journal-title":"Clin Exp Immunol"},{"key":"536_CR42","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","volume":"160","author":"D Sansonno","year":"1998","unstructured":"Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol. 1998;160:3594\u2013601.","journal-title":"J Immunol"},{"key":"536_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8","volume":"43","author":"S Vita De","year":"2000","unstructured":"De Vita S, De Re V, Gasparotto D, Ballar\u00e8 M, Pivetta B, Ferraccioli G, et al. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum. 2000;43:94\u2013102.","journal-title":"Arthritis Rheum"},{"key":"536_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1473-3099(05)70053-0","volume":"5","author":"D Sansonno","year":"2005","unstructured":"Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227\u201336.","journal-title":"Lancet Infect Dis"},{"key":"536_CR45","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.berh.2008.09.001","volume":"22","author":"M Cutolo","year":"2008","unstructured":"Cutolo M, Pizzorni C, Secchi ME, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2008;22:1093\u2013108.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"536_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","volume":"49","author":"D Roccatello","year":"2007","unstructured":"Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007;49:69\u201382.","journal-title":"Am J Kidney Dis"},{"key":"536_CR47","first-page":"484","volume":"32","author":"M Casato","year":"2005","unstructured":"Casato M, Saadoun D, Marchetti A, Limal N, Picq C, Pantano P, et al. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol. 2005;32:484\u20138.","journal-title":"J Rheumatol"},{"key":"536_CR48","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.3748\/wjg.v21.i42.11974","volume":"21","author":"S Monaco","year":"2015","unstructured":"Monaco S, Mariotto S, Ferrari S, Calabrese M, Zanusso G, Gajofatto A, Sansonno D, Dammacco F. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: advances in 2015. World J Gastroenterol. 2015;21:11974\u201383.","journal-title":"World J Gastroenterol"},{"key":"536_CR49","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/art.1780361119","volume":"36","author":"LH Zackrison","year":"1993","unstructured":"Zackrison LH, Katz P. Bronchiolitis obliterans organizing pneumonia associated with essential mixed cryoglobulinemia. Arthritis Rheum. 1993;36:1627\u201330.","journal-title":"Arthritis Rheum"},{"key":"536_CR50","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/gut.2010.218123","volume":"59","author":"B Terrier","year":"2010","unstructured":"Terrier B, Saadoun D, S\u00e8ne D, Scerra S, Musset L, Cacoub P. Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients. Gut. 2010;59:1709\u201315.","journal-title":"Gut"},{"key":"536_CR51","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0002-8703(96)90195-7","volume":"131","author":"TF Culclasure","year":"1996","unstructured":"Culclasure TF, Dorogy ME, Enzenauer RJ. Cryoglobulinemia: a reversible cause of dilated cardiomyopathy. Am Heart J. 1996;131:1044\u20136.","journal-title":"Am Heart J"},{"key":"536_CR52","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jacc.2009.09.042","volume":"55","author":"A Karras","year":"2010","unstructured":"Karras A, Potier L, Reboux AH, Coldea N, Perdrix L, Jacquot C, et al. Cryoglobulin-induced cardiomyopathy. J Am Coll Cardiol. 2010;55:e13.","journal-title":"J Am Coll Cardiol"},{"key":"536_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.amjcard.2012.09.028","volume":"111","author":"B Terrier","year":"2013","unstructured":"Terrier B, Karras A, Cluzel P, Collet JP, S\u00e8ne D, Saadoun D, et al. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis. Am J Cardiol. 2013;111:265\u201372.","journal-title":"Am J Cardiol"},{"key":"536_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/1389450116666150907103622","volume":"18","author":"M Sebastiani","year":"2017","unstructured":"Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Gragnani L, Antonelli A, et al. HCV-related rheumatic manifestations and therapeutic strategies. Curr Drug Targets. 2017;18:803\u201310.","journal-title":"Curr Drug Targets"},{"key":"536_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jbspin.2006.05.005","volume":"73","author":"C Lormeau","year":"2006","unstructured":"Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine. 2006;73:633\u20138.","journal-title":"Joint Bone Spine"},{"key":"536_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar3865","volume":"14","author":"C Ferri","year":"2012","unstructured":"Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, Giuggioli D. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther. 2012;14:215.","journal-title":"Arthritis Res Ther"},{"key":"536_CR57","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1007\/s00198-005-1858-8","volume":"16","author":"CE Fiore","year":"2005","unstructured":"Fiore CE, Riccobene S, Mangiafico R, Santoro F, Pennisi P. Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG\/RANKL system. Osteoporos Int. 2005;16:2180\u20134.","journal-title":"Osteoporos Int"},{"key":"536_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10067-004-1031-3","volume":"24","author":"P Manganelli","year":"2005","unstructured":"Manganelli P, Giuliani N, Fietta P, Mancini C, Lazzaretti M, Pollini A, et al. OPG\/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key? Clin Rheumatol. 2005;24:296\u2013300.","journal-title":"Clin Rheumatol"},{"key":"536_CR59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-2003-44555","volume":"29","author":"A Della Rossa","year":"2003","unstructured":"Della Rossa A, Tavoni A, Bombardieri S. Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations. Semin Thromb Hemost. 2003;29:473\u20137.","journal-title":"Semin Thromb Hemost"},{"key":"536_CR60","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","volume":"119","author":"MJ Stone","year":"2012","unstructured":"Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119:2205\u20138.","journal-title":"Blood"},{"key":"536_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.autrev.2008.07.017","volume":"8","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev. 2008;8:18\u201323.","journal-title":"Autoimmun Rev"},{"key":"536_CR62","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fendo.2017.00159","volume":"8","author":"C Ferri","year":"2017","unstructured":"Ferri C, Colaci M, Fallahi P, Ferrari SM, Antonelli A, Giuggioli D. Thyroid involvement in hepatitis C virus-infected patients with\/without mixed cryoglobulinemia. Front Endocrinol (Lausanne). 2017;8:159.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"536_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","volume":"33","author":"C Ferri","year":"2004","unstructured":"Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33(6):355\u201374.","journal-title":"Semin Arthritis Rheum"},{"key":"536_CR64","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3899\/jrheum.090790","volume":"37","author":"DA Landau","year":"2010","unstructured":"Landau DA, Scerra S, Sene D, Resche-Rigon M, Saadoun D, Cacoub P. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. J Rheumatol. 2010;37:615\u201321.","journal-title":"J Rheumatol"},{"key":"536_CR65","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/liv.13465","volume":"37","author":"P Cacoub","year":"2017","unstructured":"Cacoub P, Vautier M, Desbois AC, Lafuma A, Saadoun D. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon-based to direct-acting antivirals era. Liver Int. 2017;37:1805\u201313.","journal-title":"Liver Int"},{"key":"536_CR66","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","volume":"125","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Garc\u00eda-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723\u201332.","journal-title":"Gastroenterology"},{"key":"536_CR67","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/archinte.165.1.101","volume":"165","author":"G Monti","year":"2005","unstructured":"Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G, et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med. 2005;165:101\u20135.","journal-title":"Arch Intern Med"},{"key":"536_CR68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","volume":"6","author":"S Sanjose de","year":"2008","unstructured":"de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6:451\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"536_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","volume":"11","author":"AL Zignego","year":"2015","unstructured":"Zignego AL, Gragnani L, Piluso A, Sebastiani M, Giuggioli D, Fallahi P, et al. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol. 2015;11:15\u201331.","journal-title":"Expert Rev Clin Immunol"},{"key":"536_CR70","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/ijc.29845","volume":"138","author":"T Iqbal","year":"2016","unstructured":"Iqbal T, Mahale P, Turturro F, Kyvernitakis A, Torres HA. Prevalence and association of hepatitis C virus infection with different types of lymphoma. Int J Cancer. 2016;138:1035\u20137.","journal-title":"Int J Cancer"},{"key":"536_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/annonc\/mdx635","volume":"29","author":"L Couronn\u00e9","year":"2018","unstructured":"Couronn\u00e9 L, Bachy E, Roulland S, Nadel B, Davi F, Armand M, et al. From hepatitis C virus infection to B-cell lymphoma. Ann Oncol. 2018;29:92\u2013100.","journal-title":"Ann Oncol"},{"key":"536_CR72","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V88.12.4638.bloodjournal88124638","volume":"88","author":"D Sansonno","year":"1996","unstructured":"Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood. 1996;88:4638\u201345.","journal-title":"Blood"},{"key":"536_CR73","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3324\/haematol.2013.094318","volume":"99","author":"M Merli","year":"2014","unstructured":"Merli M, Visco C, Spina M, Luminari S, Ferretti VV, Gotti M, et al. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica. 2014;99:489\u201396.","journal-title":"Haematologica"},{"key":"536_CR74","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jvh.12518","volume":"23","author":"J Peveling-Oberhag","year":"2016","unstructured":"Peveling-Oberhag J, Arcaini L, Bankov K, Zeuzem S, Herrmann E. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis. J Viral Hepat. 2016;23:536\u201344.","journal-title":"J Viral Hepat"},{"key":"536_CR75","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"L Maso Dal","year":"2006","unstructured":"Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078\u201385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"536_CR76","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","volume":"102","author":"A Mele","year":"2003","unstructured":"Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood. 2003;102:996\u20139.","journal-title":"Blood"},{"key":"536_CR77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.critrevonc.2014.10.008","volume":"93","author":"S Paydas","year":"2015","unstructured":"Paydas S. Hepatitis C virus and lymphoma. Crit Rev Oncol Hematol. 2015;93:246\u201356.","journal-title":"Crit Rev Oncol Hematol"},{"key":"536_CR78","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","volume":"24","author":"C Besson","year":"2006","unstructured":"Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Groupe d\u2019Etude des Lymphomes de l\u2019Adulte Programs, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs. J Clin Oncol. 2006;24:953\u201360.","journal-title":"J Clin Oncol"},{"key":"536_CR79","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","volume":"128","author":"L Arcaini","year":"2016","unstructured":"Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, et al. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood. 2016;128:2527\u201332.","journal-title":"Blood"},{"key":"536_CR80","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.amjmed.2007.06.022","volume":"120","author":"Y Kawamura","year":"2007","unstructured":"Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, et al. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am J Med. 2007;120:1034\u201341.","journal-title":"Am J Med"},{"key":"536_CR81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013;59:169\u201377.","journal-title":"J Hepatol"},{"key":"536_CR82","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1172\/JCI118485","volume":"97","author":"H Lerat","year":"1996","unstructured":"Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest. 1996;97:845\u201351.","journal-title":"J Clin Invest"},{"key":"536_CR83","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.69.12.8079-8083.1995","volume":"69","author":"RE Lanford","year":"1995","unstructured":"Lanford RE, Chavez D, Chisari FV, Sureau C. Lack of detection of negative strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol. 1995;69:8079\u201383.","journal-title":"J Virol"},{"key":"536_CR84","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clim.2010.02.002","volume":"135","author":"M Ito","year":"2010","unstructured":"Ito M, Murakami K, Suzuki T, Mochida K, Suzuki M, Ikebuchi K, et al. Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol. 2010;135:459\u201365.","journal-title":"Clin Immunol"},{"key":"536_CR85","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1182\/blood.V92.9.3328","volume":"92","author":"D Sansonno","year":"1998","unstructured":"Sansonno D, Lotesoriere C, Cornacchiulo V, Fanelli M, Gatti P, Iodice G, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood. 1998;92:3328\u201337.","journal-title":"Blood"},{"key":"536_CR86","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A. 2004;101:4262\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR87","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1128\/JVI.03081-12","volume":"87","author":"FA Tucci","year":"2013","unstructured":"Tucci FA, Broering R, Johansson P, Schlaak JF, Kuppers R. B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes. J Virol. 2013;87:2956\u201362.","journal-title":"J Virol"},{"key":"536_CR88","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","volume":"78","author":"M Casato","year":"1991","unstructured":"Casato M, Lagan\u00e0 B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood. 1991;78:3142\u20137.","journal-title":"Blood"},{"key":"536_CR89","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","volume":"81","author":"C Ferri","year":"1993","unstructured":"Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 1993;81:1132\u20136.","journal-title":"Blood"},{"key":"536_CR90","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","volume":"84","author":"F Dammacco","year":"1994","unstructured":"Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR, et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood. 1994;84:3336\u201343.","journal-title":"Blood"},{"key":"536_CR91","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330:751\u20136.","journal-title":"N Engl J Med"},{"key":"536_CR92","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","volume":"30","author":"T Asselah","year":"2010","unstructured":"Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, Vidaud M, et al. Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver Int. 2010;30:1259\u201369.","journal-title":"Liver Int"},{"key":"536_CR93","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1002\/art.20594","volume":"50","author":"L Vallat","year":"2004","unstructured":"Vallat L, Benhamou Y, Gutierrez M, Ghillani P, Hercher C, Thibault V, et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum. 2004;50:3668\u201378.","journal-title":"Arthritis Rheum"},{"key":"536_CR94","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1182\/blood-2010-10-312942","volume":"117","author":"ED Charles","year":"2011","unstructured":"Charles ED, Brunetti C, Marukian S, Ritola KD, Talal AH, Marks K, et al. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood. 2011;117:5425\u201337.","journal-title":"Blood"},{"key":"536_CR95","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","volume":"101","author":"F Zaja","year":"2003","unstructured":"Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827\u201334.","journal-title":"Blood"},{"key":"536_CR96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","volume":"11","author":"C Ferri","year":"2011","unstructured":"Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev. 2011;11:48\u201355.","journal-title":"Autoimmun Rev"},{"key":"536_CR97","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","volume":"116","author":"F Dammacco","year":"2010","unstructured":"Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood. 2010;116:343\u201353.","journal-title":"Blood"},{"key":"536_CR98","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","volume":"116","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, et al. Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010;116:326\u201334.","journal-title":"Blood"},{"key":"536_CR99","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/art.34322","volume":"64","author":"MC Sneller","year":"2012","unstructured":"Sneller MC, Hu Z, Langford CA. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:835\u201342.","journal-title":"Arthritis Rheum"},{"key":"536_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","volume":"62","author":"D Saadoun","year":"2015","unstructured":"Saadoun D, Resche Rigon M, Pol S, Thibault V, Blanc F, Pialoux G, et al. PegIFN\u03b1\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. J Hepatol. 2015;62:24\u201330.","journal-title":"J Hepatol"},{"key":"536_CR101","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","volume":"66","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66:153\u201394.","journal-title":"J Hepatol"},{"key":"536_CR102","unstructured":"American Association for the Study of Liver Disease, Infectious Diseases Society of America. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. 2017 ( http:\/\/www.hcvguidelines.org )."},{"key":"536_CR103","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ Meer van der","year":"2012","unstructured":"van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308:2584\u201393.","journal-title":"JAMA"},{"key":"536_CR104","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.autrev.2017.03.004","volume":"16","author":"AL Zignego","year":"2017","unstructured":"Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, ISG-EHCV, et al. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017;16:523\u201341.","journal-title":"Autoimmun Rev"},{"key":"536_CR105","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jhep.2017.02.010","volume":"66","author":"M Ramos-Casals","year":"2017","unstructured":"Ramos-Casals M, Zignego AL, Ferri C, Brito-Zer\u00f3n P, Retamozo S, Casato M, International Study Group of Extrahepatic Manifestations related to HCV (ISG-EHCV), et al. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. J Hepatol. 2017;66:1282\u201399.","journal-title":"J Hepatol"},{"key":"536_CR106","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.autrev.2011.04.033","volume":"10","author":"M Visentini","year":"2011","unstructured":"Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev. 2011;10:714\u20139.","journal-title":"Autoimmun Rev"},{"key":"536_CR107","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","volume":"42","author":"MA Rockx","year":"2010","unstructured":"Rockx MA, Clark WF. Plasma exchange for treating cryoglobulinemia: a descriptive analysis. Transfus Apher Sci. 2010;42:247\u201351.","journal-title":"Transfus Apher Sci"},{"key":"536_CR108","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jca.21414","volume":"31","author":"N Olson","year":"2016","unstructured":"Olson N, Yerrabothala S, Dunbar N. Successful use of cryocrit for monitoring response to therapeutic plasma exchange in type 1 cryoglobulinemia. J Clin Apher. 2016;31:403\u20134.","journal-title":"J Clin Apher"},{"key":"536_CR109","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig M, Mari\u00f1o Z, Perell\u00f3 C, I\u00f1arrairaegui M, Ribeiro A, Lens S, et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol. 2016;65:719\u201326.","journal-title":"J Hepatol"},{"key":"536_CR110","first-page":"421","volume":"13","author":"S Grandhe","year":"2017","unstructured":"Grandhe S, Frenette CT. Occurrence and recurrence of hepatocellular carcinoma after successful direct-acting antiviral therapy for patients with chronic hepatitis C virus infection. Gastroenterol Hepatol (N Y). 2017;13:421\u20135.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"536_CR111","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","volume":"75","author":"D Saadoun","year":"2016","unstructured":"Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, et al. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2016;75:1777\u201382.","journal-title":"Ann Rheum Dis"},{"key":"536_CR112","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.28753","volume":"64","author":"L Gragnani","year":"2016","unstructured":"Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016;64:1473\u201382.","journal-title":"Hepatology"},{"key":"536_CR113","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/kew268","volume":"55","author":"S Sollima","year":"2016","unstructured":"Sollima S, Milazzo L, Peri AM, Torre A, Antinori S, Galli M. Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. Rheumatology (Oxford). 2016;55:2084\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"536_CR114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cgh.2016.09.158","volume":"15","author":"M Bonacci","year":"2017","unstructured":"Bonacci M, Lens S, Londo\u00f1o MC, Mari\u00f1o Z, Cid MC, Ramos-Casals M, et al. Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol. 2017;15:575\u201383.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"536_CR115","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13075-017-1280-6","volume":"19","author":"G Lauletta","year":"2017","unstructured":"Lauletta G, Russi S, Pavone F, Vacca A, Dammacco F. Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience. Arthritis Res Ther. 2017;19:74.","journal-title":"Arthritis Res Ther"},{"key":"536_CR116","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ajg.2017.49","volume":"112","author":"JS Emery","year":"2017","unstructured":"Emery JS, Kuczynski M, La D, Almarzooqi S, Kowgier M, Shah H, et al. Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol. 2017;112:1298\u2013308.","journal-title":"Am J Gastroenterol"},{"key":"536_CR117","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.gastro.2017.03.006","volume":"153","author":"D Saadoun","year":"2017","unstructured":"Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, et al. Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 2017;153:49\u201352.","journal-title":"Gastroenterology"},{"key":"536_CR118","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","volume":"65","author":"F Conti","year":"2016","unstructured":"Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016;65:727\u201333.","journal-title":"J Hepatol"},{"key":"536_CR119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4254\/wjh.v10.i2.267","volume":"10","author":"AS Butt","year":"2018","unstructured":"Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: biologically plausible or an epiphenomenon? World J Hepatol. 2018;10:267\u201376.","journal-title":"World J Hepatol"},{"issue":"Suppl 1","key":"536_CR120","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/liv.13659","volume":"38","author":"B Roche","year":"2018","unstructured":"Roche B, Coilly A, Duclos-Vallee JC, Samuel D. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Liver Int. 2018;38(Suppl 1):139\u201345.","journal-title":"Liver Int"},{"key":"536_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29855","author":"AC Huang","year":"2018","unstructured":"Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout. Hepatology. 2018. https:\/\/doi.org\/10.1002\/hep.29855 [Epub ahead of print].","journal-title":"Hepatology"},{"key":"536_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.009","author":"A Romano","year":"2018","unstructured":"Romano A, Angeli P, Piovesan S, Noventa F, Anastassopoulos G, Chemello L, et al. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study. J Hepatol. 2018. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.009 [Epub ahead of print].","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"536_CR123","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/S1590-8658(07)80013-2","volume":"39","author":"MT Mascia","year":"2007","unstructured":"Mascia MT, Ferrari D, Campioli D, Sandri G, Mussini C, Ferri C. Non HCV-related mixed cryoglobulinemia. Dig Liver Dis. 2007;39(Suppl 1):S61\u20134.","journal-title":"Dig Liver Dis"},{"key":"536_CR124","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","volume":"65","author":"B Terrier","year":"2015","unstructured":"Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, et al. Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015;65:74\u201381.","journal-title":"J Autoimmun"},{"issue":"Suppl 103","key":"536_CR125","first-page":"67","volume":"35","author":"M Galli","year":"2017","unstructured":"Galli M, Oreni L, Saccardo F, Castelnovo L, Filippini D, Marson P, et al. HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). Clin Exp Rheumatol. 2017;35(Suppl 103):67\u201376.","journal-title":"Clin Exp Rheumatol"},{"key":"536_CR126","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","volume":"119","author":"B Terrier","year":"2012","unstructured":"Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 2012;119:5996\u20136004.","journal-title":"Blood"},{"key":"536_CR127","doi-asserted-by":"crossref","unstructured":"Spatola L, Generali E, Angelini C, Badalamenti S, Selmi C. HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases. Clin Exp. Med 2018 (accepted for publication).","DOI":"10.1007\/s10238-018-0514-5"},{"key":"536_CR128","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/art.23305","volume":"58","author":"DA Landau","year":"2008","unstructured":"Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum. 2008;58:604\u201311.","journal-title":"Arthritis Rheum"},{"key":"536_CR129","doi-asserted-by":"crossref","first-page":"41764","DOI":"10.18632\/oncotarget.16986","volume":"8","author":"D Roccatello","year":"2017","unstructured":"Roccatello D, Sciascia S, Rossi D, Solfietti L, Fenoglio R, Menegatti E, et al. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. Oncotarget. 2017;8:41764\u201377.","journal-title":"Oncotarget"},{"key":"536_CR130","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00325481.2015.1021660","volume":"127","author":"SL Cornella","year":"2015","unstructured":"Cornella SL, Stine JG, Kelly V, Caldwell SH, Shah NL. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: a case series. Postgrad Med. 2015;127:413\u20137.","journal-title":"Postgrad Med"},{"key":"536_CR131","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-319-13150-4_7","volume":"165","author":"JJ Castillo","year":"2015","unstructured":"Castillo JJ, Ghobrial IM, Treon SP. Biology, prognosis, and therapy of Waldenstr\u00f6m Macroglobulinemia. Cancer Treat Res. 2015;165:177\u201395.","journal-title":"Cancer Treat Res"},{"key":"536_CR132","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15110","author":"LY Chen","year":"2018","unstructured":"Chen LY, Shah R, Cwynarski K, Lambert J, McNamara C, Mohamedbhai SG, et al. Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab. Br J Haematol. 2018. https:\/\/doi.org\/10.1111\/bjh.15110 [Epub ahead of print].","journal-title":"Br J Haematol"},{"key":"536_CR133","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/hep.29198","volume":"66","author":"M Merli","year":"2017","unstructured":"Merli M, Frigeni M, Gotti M, Grossi P, Bruno R, Passamonti F, et al. Direct-acting antivirals during or after immunochemotherapy in hepatitis C virus-positive diffuse large B-cell lymphomas. Hepatology. 2017;66:1341\u20133.","journal-title":"Hepatology"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-018-0536-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0536-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0536-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T02:35:30Z","timestamp":1694054130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-018-0536-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s10238-018-0536-z","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"6 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no competing financial interests in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}